Wegovy Maker Novo Shares Slump as Management Grilled on Pricing, M&A

Jyllands-Posten

Lean Right

Factuality

Ownership

On Monday's Capital Markets Day, Mike Doustdar himself highlighted the "elephant in the room", but if you ask two analysts, it was just one of several topics that the market wanted answers to.

berlingske.dk

Lean Right

Factuality

Ownership

Novo CEO Mike Doustdar will answer a number of questions from analysts and investors on Monday. This will take place at the company's Capital Markets Day, where Novo's future portfolio of drugs will once again be high on the agenda, analysts estimate.

borsen.dk

Factuality

Ownership

Analyst assessed that Novo's capital markets day was like a meltdown

moneytimes.com.br

Factuality

Ownership

Novo Nordisk's actions retreated on Monday, while executives faced difficult questions from analysts about the power of pharmaceutical precision and its strategy of mergers and acquisitions, faced with the proximity of the expiration of important patents. Novo intends to launch more than five highly successful drugs by 2030 and generate more than 150 [...]